Wednesday, 26 December 2018

Barcode Printers Market Expected To Trigger A Revenue Increase To USD 3.81 Billion By 2020


San Francisco, 24 December 2018, Barcode Printers Market Analysis By Product (Mobile, Desktop, Industrial/Tabletop), By Technology (Thermal Transfer, Direct Thermal, Laser, Impact, Ink-Jet), By End-Use (Healthcare, Manufacturing, Retail, Shipping, Government) And Segment Forecasts To 2020

The global barcode printers market is expected to reach USD 3.81 billion by 2020, according to a new study by Grand View Research, Inc. Increased demand for mobile barcode printers is expected to drive market growth over the forecast period. Implementation of bar-coded wristbands for personal identification in hospitals and events has augmented the demand for mobile barcode printers.
Growth of organized retail stores worldwide has significantly driven the barcode printers market, as products equipped with barcode tags enable faster and more efficient check-outs. Growing adoption of Radio Frequency Identification (RFID) may pose a challenge to market growth over the next six years owing to the numerous advantages offered by the technology, such as dynamic storage of information which can be updated periodically.
Access Full Research Report On Barcode Printers Market  Analysis:
www.grandviewresearch.com/industry-analysis/barcode-printers-market
Further key findings from the study suggest:
·         Industrial printers dominated the barcode printers market in 2013, accounting for over 60% of the overall revenue share. Mobile printers are expected to witness high growth over the forecast period owing to their ease of use and utility in numerous field-based applications; they have been increasingly used by organizations’ salespeople in order to conduct business and issue authentic invoices and receipts irrespective of the time and place.
·         Thermal technology based printers accounted for over 60% of the market share as compared to their non-thermal counterparts, primarily because of their reliability, high speed, low noise and provision for easy cleaning. Among thermal technology based printers, the direct thermal technology is expected to witness significant growth over the forecast period owing to enhanced durability, low operational costs and elimination of the need for disposing used ink ribbons, making it more eco-friendly.
·         Manufacturing applications led the market in 2013, accounting for over 35% of the overall revenue. Retail and healthcare are expected to be lucrative fields for the barcode printers market over the forecast period, with both projected to witness high growth rates. In healthcare, barcode printers have been extensively used for printing tags used in patient ID systems in order to prevent medical errors by enabling access to accurate patient information for surgical procedures and specimen collection.
·         North America dominated the market in 2013, accounting for over 40% of the overall revenue. Asia Pacific is expected to witness high growth rate over the forecast period.
·         The market has become increasingly consolidated owing to significant mergers and acquisitions in order to achieve growth across several product categories, verticals, and regions; for instance Honeywell’s acquisition of Intermec and SATO’s acquisition of Argox. Vendors have to deal with low profit margins owing to the highly commoditized nature of the market.
Browse More Reports Of This Category By Grand View Research At:  www.grandviewresearch.com/industry/electronic-devices
Grand View Research has segmented the global barcode printers market on the basis of product, technology, end-use and region:
Barcode Printers Product Outlook (USD Million, 2012 - 2020)
·         Desktop
·         Mobile
·         Industrial
Barcode Printers Technology Outlook (USD Million, 2012 - 2020)
·         Thermal Transfer
·         Direct Thermal
·         Laser
·         Impact
·         Ink-Jet
Barcode Printers End-Use Outlook (USD Million, 2012 - 2020)
·         Healthcare
·         Manufacturing
·         Retail
·         Shipping
·         Government
Barcode Printers Regional Outlook (USD Million, 2012 - 2020)
·         North America
·         EMEA
·         Asia Pacific
·         Latin America

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/



at No comments:

Electrodes For Medical Devices Market Expected To Trigger A Revenue Increase To USD 2.0 Billion By 2025:Key Participant GE Healthcare, C.R Bard Inc.


San Francisco, 24 December 2018, Electrodes For Medical Devices Market Analysis By Type {Diagnostics (ECG, EEG, EMG, ERG, Fetal Scalp), Therapeutics (Pacemaker, TENS, Defibrillator, Electrosurgical)}, By Region, And Segment Forecasts, 2018 – 2025

The global electrodes for medical devices market is expected to reach USD 2.0 billion by 2025, according to a new report by Grand View Research, Inc. The market is anticipated to witness lucrative growth during the forecast period, owing to increasing prevalence of chronic and other diseases such as heart diseases, Parkinson’s Disease (PD), Alzheimer’s disease, brain disorders, Trigeminal Neuralgia (TN or TGN), sinusitis, tinnitus, Raynaud's disease, fibromyalgia, circulatory disturbances, gout, and body ache, across the globe. 
Minimally Invasive Surgery (MIS) is one of the advancements in medical technology in which small incisions are made in the body for laparoscopy, endoscopy, arthroscopy, and other surgical procedures. This procedure is gaining popularity owing to faster recovery, lesser postsurgical infections, pain, & major bleeding, reduced scarring, and high accuracy benefits. In 2015, over 20.0 million Americans underwent MIS, which is expected to assist in the growth of this vertical during the forecast period.
Access Full Research Report On Electrodes For Medical Devices Market Analysis:

Further Key Findings From the Study Suggest:
·         The diagnostic segment held a profitable revenue share in 2016 and is expected to grow at a significant rate over the forecast period.
·         Rising prevalence of heart diseases, fetal distress syndrome, ocular diseases, and neurological disorders make extensive use of Electrocardiogram (ECG), Electroencephalogram (EEG), electrosurgical, and fetal scalp electrodes
·         The therapeutic segment is anticipated to witness the fastest growth over the forecast period due to widened use of medical electrodes in aesthetic surgeries, RF ablation procedures, neurosurgical procedures, and acute & chronic pain treatments
·         Defibrillator and electrosurgical electrodes are projected to hold substantial market share over the forecast period. This can be attributed to the advanced development of wearable defibrillator that constantly monitors the cardiac rhythms of the wearer and identifies & notifies the user about the occurrence of any abnormality and helps regain the normal heart functionality
·         North America is expected to dominate the medical electrodes market during the forecast period, owing to the rising prevalence of CVDs, changing lifestyle of individuals, and presence of target population in the U.S. and Canada. In addition, the presence of advanced technologies with electrodes such as hydrogel and dry electrodes in the region are expected to spur the medical electrodes market growth.
·         Some of the key players in medical electrodes market are 3M Healthcare; Boston Scientific Corporation; GE Healthcare; C.R Bard Inc.; CONMED Corporation; Medtronic; Natus Medical Incorporated; Thermo Fisher Scientific Inc.; Asahi Kasei Corporation; and Philips Healthcare
Browse More Reports Of This Category By Grand View Research At:  www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global electrodes for medical devices market on the basis of type and region:
Electrodes For Medical Devices Type Outlook (Revenue, USD Million, 2014 - 2025)
·         Diagnostics
o    Electrocardiogram (ECG)
o    Electroencephalogram (EEG)
o    Electromyogram (EMG)
o    Electroretinogram (ERG)
o    Fetal Scalp
o    Other
·         Therapeutics
o    Pacemaker
o    Transcutaneous Electrical Nerve Stimulator (TENS)
o    Defibrillator
o    Electrosurgical
o    Other
Electrodes For Medical Devices Regional Outlook (Revenue, USD Million, 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    UK
·         Asia Pacific
o    Japan
o    China
·         Latin America
o    Brazil
o    Mexico
·         Middle East and Africa (MEA)
o    South Africa


About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/



at No comments:
Labels: , , , ,

Pulmonary Arterial Hypertension Market Expected To Trigger A Revenue Increase To USD 8.7 Billion By 2025:Key Participant Actelion Pharmaceuticals, Ltd.



San Francisco, 26 December 2018, Pulmonary Arterial Hypertension (PAH) Market By Drug Class (Prostacyclin And Prostacyclin Analogs, Soluble Guanylate Cyclase (SGC) Stimulators, Endothelin Receptor Antagonists (ERA), Phosphodiesterase 5 (PDE-5)) And Segment Forecasts To 2025

The pulmonary arterial hypertension (PAH) market is expected to reach USD 8.7 billion by 2025, according to the new report by Grand View Research, Inc. Incidents of PAH, increasing geriatric population, and government support to develop orphan drugs are key driving factors. Cumulatively, the cases of PAH are in the range of 100,000 to 200,000 per year. However, in the past few years, the prevalence of this disorder is rising due to risk factors like sedentary lifestyle, HIV, smoking, alcohol/tobacco consumption, and other idiopathic conditions. 
The presence of a large population over 60 years globally, which has lower immunity levels and is prone to PAH and associated diseases, which is a high impact-rendering driver for the growth of the market over the forecast period. 
Supportive government initiatives for the development of drugs for rare diseases or orphan drugs are anticipated to facilitate the market growth over the forecast period. For instance, the Orphan Drug Act (ODA) 1983, and Rare Disease Act 2002 in the U.S. offer incentives such as tax credits for the development of orphan drugs. 
Patent expiry of key PAH molecules is projected to have a deep impact on market dynamics. In coming two to four years the exclusivity of key brands such as Tracleer, Remodulin, Adcirca, Ventavis, Tyvaso, and Letairis will be lost. This will foster the entry of generic product at prices much lower than branded drugs.
Access Full Research Report On Pulmonary Arterial Hypertension (PAH) Market  Analysis:
www.grandviewresearch.com/industry-analysis/pulmonary-arterial-hypertension-market

Further Key Findings From the Study Suggest: 
·         ERA dominated PAH market with a substantial share of around 40.0% in 2015. Tracleer and Opsumit target both the ETA and ETB receptors, whereas Letairis/Volibris targets only the ETA receptor. The cumulative sales from these drugs are expected to marginally decline over the next few years. 
·         Prostacyclin and prostacyclin analogues are anticipated to exhibit lucrative growth over the forecast period. The sales of these drugs are expected to grow sharply over the forecast period, primarily due to the growth expected in oral prostacyclin agents (Uptravi and Orenitram). Adempas, a SGC stimulator launched in 2013, is expected to grow at a healthy rate during forecast period. 
·         North America with its supportive infrastructure for development and distribution of high quality therapies dominated global pulmonary arterial hypertension market with more than 50.0% share in 2015. High awareness and well planned reimbursement structure resulted in superlative diagnosis rate ultimately impacting treatment rate. 
·         On the other hand, Asia Pacific with its rapid economic developments, huge population base and improving healthcare systems is anticipated to grow at a lucrative growth rate. Economic developments in countries such as India and China are complimenting the growth of this region.
·         Some of the key players in this vertical are Actelion Pharmaceuticals, Ltd., Gilead Sciences, Inc., Gilead Sciences, Inc., United Therapeutics Corporation, GlaxoSmithKline Plc. and Pfizer, Inc..The firms are involved in adopting many mergers, acquisition, strategic collaboration and geographical expansion in order to maximize its revenue.
·         For instance, in January 2016, Actelion Pharmaceuticals, Ltd. announced commercial availability of Uptravi (Slelximab) in the U.S., which was previously approved in December 2015. This initiative helped company to strengthen its leadership in PAH portfolio. 
Browse More Reports Of This Category By Grand View Research At:  www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the PAH market on the basis of drug class and region: 
Global PAH Drug Class Outlook (Revenue, USD Million, 2014 - 2025)
·         Prostacyclin and Prostacyclin Analogs
·         SGC Stimulators
·         ERA
·         PDE-5 
PAH Regional Outlook (Revenue, USD Million, 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    UK
o    Germany
·         Asia Pacific
o    Japan
o    China
·         Latin America
o    Brazil
o    Mexico
·         MEA
o    South Africa


About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/



at No comments:
Subscribe to: Posts (Atom)